Long-term therapy of Wilson's disease.
D000293:Adolescent; D000328:Adult; D001772:Blood Cell Count; D002490:Central Nervous System / Q000503:physiopathology; D002648:Child; D003300:Copper / Q000378:metabolism; D003315:Cornea / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008099:Liver / Q000503:physiopathology; D008134:Long-Term Care; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage* / Q000009:adverse effects; D010858:Pigmentation; D011188:Potassium / Q000008:administration & dosage* / Q000009:adverse effects; D013440:Sulfides / Q000008:administration & dosage* / Q000009:adverse effects
D013440:Sulfides; D003300:Copper; D010396:Penicillamine; D011188:Potassium